AMPlify is an accelerated market entry platform, and US ecosystem, designed for Finnish healthcare companies by Business Finland in collaboration with the Mayo Clinic.
The US market represents 40% of the global healthcare market and more than 30% of new technologies are joint ventures with non-US entities. American health systems are transitioning their innovation centers into international co-development platforms. AMPlify is part of this transition.
Entry into the US healthcare market is accelerated by having local champions. AMPlify provides this advantage.
Mayo Clinic is one of the leading hospitals in the US, and its goal is to provide innovative solutions for patients. They are seeking new ways to improve care, reduce costs, and improve the quality of life of patients. Co-development is key to entry and sustainable growth.
The need for more and better digital tools is real and visible. Now is the time to focus resources on US entry through AMPlify, a proven platforms for Finnish healthcare companies.
The AMPlify program is a comprehensive healthcare ecosystem designed for Finnish companies. Working with Business Finland and the Mayo Clinic, participating companies will receive feedback and access to KOLs while gaining market and business insight. All aspects of commercial and clinical success will be covered.
AMPlify will shorten your time to market.
- There are 10-12 openings for the 2024 program
- AMPlify kick-off in Helsinki at the end of August
- All applications must be submitted by August 7, 2024
- Company selection will be announced mid-August with feedback from Mayo for all applicants
- Virtual, bi-weekly workshops
- November 6-9, 2024: Visit to Mayo Clinic, Rochester, Minnesota
